ロード中...
ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and become pandemic with thousands new deaths and infected cases globally. To address coronavirus disease (COVID-19), currently no effective drug or vaccine is available. This necessity motivated us to e...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7794216/ https://ncbi.nlm.nih.gov/pubmed/33420186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79918-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|